J-E Lee1, E-J Hong, H-Y Nam, J-W Kim, B-G Han, J-P Jeon. 1. Center for Genome Science, Korea National Institute of Health, Korea Centers for Disease Control and Prevention, Seoul, South Korea.
Abstract
OBJECTIVE: MicroRNAs (miRNAs) are negative regulators of gene expression that play important roles in cell processes such as proliferation, development and differentiation. Recently, it has been reported that miRNAs are related to development of carcinogenesis. The aim of this study was to identify miRNAs associated with terminal immortalization of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell line (LCL) and associated clinical traits. MATERIAL AND METHODS: Hence, we performed miRNA microarray approach with early- (p6) and late-passage (p161) LCLs. RESULTS AND CONCLUSION: Microarray data showed that nine miRNAs (miR-20b*, miR-28-5p, miR-99a, miR-125b, miR-151-3p, miR-151:9.1, miR-216a, miR-223* and miR-1296) were differentially expressed in most LCLs during long-term culture. In particular, miR-125b was up-regulated in all the tested late-passage LCLs. miR-99a, miR-125b, miR-216a and miR-1296 were putative negative regulators of RASGRP3, GPR160, PRKCH and XAF1, respectively, which were found to be differentially expressed in LCLs during long-term culture in a previous study. Linear regression analysis showed that miR-200a and miR-296-3p correlated with triglyceride and HbA1C levels, respectively, suggesting that miRNA signatures of LCLs could provide information on the donor's health. In conclusion, our study suggests that expression changes of specific miRNAs may be required for terminal immortalization of LCLs. Thus, differentially expressed miRNAs would be a potential marker for completion of cell immortalization during EBV-mediated tumorigenesis.
OBJECTIVE: MicroRNAs (miRNAs) are negative regulators of gene expression that play important roles in cell processes such as proliferation, development and differentiation. Recently, it has been reported that miRNAs are related to development of carcinogenesis. The aim of this study was to identify miRNAs associated with terminal immortalization of Epstein-Barr virus (EBV)-transformed lymphoblastoid cell line (LCL) and associated clinical traits. MATERIAL AND METHODS: Hence, we performed miRNA microarray approach with early- (p6) and late-passage (p161) LCLs. RESULTS AND CONCLUSION: Microarray data showed that nine miRNAs (miR-20b*, miR-28-5p, miR-99a, miR-125b, miR-151-3p, miR-151:9.1, miR-216a, miR-223* and miR-1296) were differentially expressed in most LCLs during long-term culture. In particular, miR-125b was up-regulated in all the tested late-passage LCLs. miR-99a, miR-125b, miR-216a and miR-1296 were putative negative regulators of RASGRP3, GPR160, PRKCH and XAF1, respectively, which were found to be differentially expressed in LCLs during long-term culture in a previous study. Linear regression analysis showed that miR-200a and miR-296-3p correlated with triglyceride and HbA1C levels, respectively, suggesting that miRNA signatures of LCLs could provide information on the donor's health. In conclusion, our study suggests that expression changes of specific miRNAs may be required for terminal immortalization of LCLs. Thus, differentially expressed miRNAs would be a potential marker for completion of cell immortalization during EBV-mediated tumorigenesis.
Authors: Valerie W Hu; Tewarit Sarachana; Kyung Soon Kim; AnhThu Nguyen; Shreya Kulkarni; Mara E Steinberg; Truong Luu; Yinglei Lai; Norman H Lee Journal: Autism Res Date: 2009-04 Impact factor: 5.216
Authors: Jennifer E Cameron; Claire Fewell; Qinyan Yin; Jane McBride; Xia Wang; Zhen Lin; Erik K Flemington Journal: Virology Date: 2008-10-31 Impact factor: 3.616
Authors: S Y Baik; H S Yun; H J Lee; M H Lee; S E Jung; J W Kim; J P Jeon; Y K Shin; H S Rhee; K C Kimm; B G Han Journal: Cell Prolif Date: 2007-04 Impact factor: 6.831
Authors: Katia R M Leite; Juliana M Sousa-Canavez; Sabrina T Reis; Alberto H Tomiyama; Luiz H Camara-Lopes; Adriana Sañudo; Alberto A Antunes; Miguel Srougi Journal: Urol Oncol Date: 2009-04-16 Impact factor: 3.498